U.S. Communications Stock News

NYSE:NU
NYSE:NUBanks

Nu Holdings (NU) 41.9% Net Margin Tests Bearish Credit‑Risk Narrative After Q1 2026 Results

Nu Holdings (NYSE:NU) opened Q1 2026 with total revenue of US$1.98 billion and basic EPS of US$0.18, setting a clear marker for its latest quarter at a share price of US$12.19. Over the past year, the company has seen revenue move from US$1.38 billion in Q1 2025 to US$1.98 billion in Q1 2026, while basic EPS moved from US$0.12 to US$0.18 over the same period, framing a steadily larger profit pool for shareholders. Taken together with trailing net income of US$3.18 billion and a reported net...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Has Johnson & Johnson (JNJ) Run Too Far After A 54% One-Year Surge?

Wondering if Johnson & Johnson at around US$226.71 is still a fair deal, or if the stock has already run too far for comfort. The stock closed at US$226.71, with a 2.4% gain over the last week, a 9.3% gain year to date, and a 54.0% gain over the last year. The past month shows a 3.2% decline that may reflect some cooling or a shift in risk appetite. Recent headlines have focused on Johnson & Johnson's ongoing product portfolio, legal developments, and healthcare sector trends. These factors...
NasdaqGS:MGRC
NasdaqGS:MGRCTrade Distributors

A Look At McGrath RentCorp (MGRC) Valuation After Its Expanded US$725 Million Credit Facility Completion

McGrath RentCorp (MGRC) has secured a new five year, US$725 million credit facility that replaces its prior US$650 million line. This financing move directly affects funding capacity and balance sheet flexibility. See our latest analysis for McGrath RentCorp. The new US$725 million facility comes as the share price has eased in the short term, with a 1 month share price return of down 3.15% and a 3 month share price return of down 5.01%. At the same time, the year to date share price return...
NasdaqGM:KALV
NasdaqGM:KALVBiotechs

Assessing KalVista Pharmaceuticals (KALV) Valuation After Strong Recent Share Price Momentum

Recent stock performance context for KalVista Pharmaceuticals KalVista Pharmaceuticals (KALV) has drawn fresh attention after a strong share price move, with the stock up about 31% over the past month and roughly 79% over the past 3 months. See our latest analysis for KalVista Pharmaceuticals. That recent surge sits on top of a much stronger long-term picture, with a 1-year total shareholder return of 124.06% and a 3-year total shareholder return of 153.85%, signalling firm upward momentum...
NYSE:SRG
NYSE:SRGReal Estate

Seritage Growth Properties (SRG) Q4 EPS Loss Tightening Challenges Pure Wind Down Narrative

Seritage Growth Properties Q1 2026 Earnings Snapshot Seritage Growth Properties (SRG) has opened Q1 2026 reporting season with recent revenue of US$4.6 million in Q4 2025 and basic EPS of US$0.11 loss per share, setting the tone for how investors will be weighing the latest numbers against past results. The company has seen quarterly revenue move from US$3.4 million in Q3 2024 to US$5.4 million in Q3 2025 and US$4.6 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$0.41 per...
NYSE:KWR
NYSE:KWRChemicals

Is It Time To Reassess Quaker Chemical (KWR) After Its Recent Share Price Recovery

Investors may be wondering whether Quaker Chemical at around US$137.99 is still offering value, or if most of the easy gains are already behind it. The stock is down about 6.5% over the last week and 1.3% over the last month, roughly flat year to date with a 0.7% decline, yet still up 31.1% over the past year after longer term declines of 31.4% over three years and 37.0% over five years. Recent coverage has focused on Quaker Chemical's position in the specialty chemicals sector and how...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Shopify (SHOP) Valuation Check After Strong Q1 Results Cautious Guidance And AI Legal And Integration Updates

Shopify (SHOP) is back in focus after a busy few weeks, with strong Q1 2026 results, cautious guidance, fresh AI debates, legal developments, and a new EZ Texting integration all influencing how investors view the stock. See our latest analysis for Shopify. The recent mix of strong Q1 results, softer near term guidance, AI related cost concerns, and fresh legal and governance headlines has coincided with pressure on the stock, with the share price down 36.21% year to date. However, the three...
NasdaqCM:NEOV
NasdaqCM:NEOVElectrical

NeoVolta (NEOV) Loss Worsens To US$5.5 Million Challenging Path To Profit Narrative

NeoVolta (NEOV) has just posted another loss making quarter, with Q2 2026 revenue at US$4.6 million and a basic EPS loss of US$0.16, alongside net income excluding extra items of a US$5.5 million loss. The company has seen revenue move from US$0.6 million in Q1 2025 to US$6.7 million in Q1 2026, while quarterly EPS has ranged from a loss of US$0.03 to US$0.16 over that stretch. This has left investors focused on how quickly margins can tighten toward breakeven. See our full analysis for...
NYSE:NPK
NYSE:NPKAerospace & Defense

Margin Compression To 6.2% Tests Bullish Narratives On National Presto Industries Q1 2026 Results

Q1 2026 headline results set the tone National Presto Industries (NPK) opened 2026 with Q1 revenue of US$118.6 million and basic EPS of US$0.93, putting fresh numbers on the table for investors weighing the recent move in the stock around US$137.98. The company has seen quarterly revenue range from US$103.6 million in Q1 2025 to US$163.9 million in Q4 2025, while basic EPS moved between US$0.72 and US$2.10 over the same period. This gives you a clear sense of how the top and bottom lines have...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

Should Disc Medicine’s RALLY-MF Data and Wider Pipeline Reveal a Pivotal Inflection for IRON’s Narrative?

Disc Medicine, Inc. reported a first-quarter 2026 net loss of US$63.5 million, with basic loss per share from continuing operations of US$1.65, while also preparing to present new data from multiple hematology programs at the European Hematology Association Congress. The upcoming RALLY-MF phase 2 and bitopertin data presentations at a major hematology meeting highlight how much of Disc Medicine’s story now hinges on clinical progress rather than current earnings. Next, we’ll examine how the...
OTCPK:HKHC
OTCPK:HKHCPersonal Products

Horizon Kinetics Holding (OTCPK:HKHC) Revenue Growth Tests Bullish Narratives On Margins

Horizon Kinetics Holding (OTCPK:HKHC) Q1 2026 results in focus Horizon Kinetics Holding (OTCPK:HKHC) has followed up a volatile 2025 with Q1 2026 results that sit against a trailing 12 month backdrop of US$72.8 million in revenue and Basic EPS of US$0.34, after a year that also included a one off loss of US$33.7 million. Over recent periods, the company has seen quarterly revenue move from US$18.2 million in Q4 2024 to US$19.8 million in Q1 2025, then to US$17.9 million in Q3 2025 and US$17.0...
NYSE:RF
NYSE:RFBanks

A Look At Regions Financial (RF) Valuation After Fed Signals No Rate Cuts In 2026

The recent drop in Regions Financial (RF) stock was sparked by the Federal Reserve signaling no interest rate cuts in 2026. This stance pressured regional banks as investors reconsidered lending and margin expectations. See our latest analysis for Regions Financial. Beyond the immediate reaction to the Federal Reserve comments, Regions Financial’s share price has been under pressure in recent weeks. The 30 day share price return is down 5.23% and the 90 day share price return is down 10.36%...
NYSE:CBT
NYSE:CBTChemicals

A Look At Cabot (CBT) Valuation As Shares Trade Near DCF Estimate With A 14.9x P/E Ratio

Cabot stock at a glance Cabot (CBT) has drawn fresh attention after recent trading left the stock at US$81. For investors, that price sits alongside a reported US$3,575.0m in revenue and US$281.0m in net income. See our latest analysis for Cabot. Recent trading has been choppy, with the share price down over 1 day and over the past week. However, a 30-day share price return of 8.83% and a year-to-date share price return of 20.81% sit alongside a 1-year total shareholder return of 8.39%,...
NYSE:NVT
NYSE:NVTElectrical

A Look At nVent Electric (NVT) Valuation After Record Q1 Results And New US$500 Million Buyback

nVent Electric (NVT) is back in focus after a series of company-specific developments, including record first quarter results, a new US$500 million share repurchase authorization, and confirmation of its regular cash dividend. See our latest analysis for nVent Electric. The stock has pulled back 2.85% on a 1-day share price basis to US$169.01 and is slightly lower over 7 days. However, the 30-day share price return of 25.48% and 1-year total shareholder return of 152.16% point to strong...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

Assessing MoonLake Immunotherapeutics (MLTX) Valuation After Positive FDA Pre BLA Outcome For Sonelokimab

MoonLake Immunotherapeutics (MLTX) has cleared a key regulatory step by completing a final pre-BLA meeting with the FDA for sonelokimab in hidradenitis suppurativa, achieving alignment on efficacy, safety data inclusion, and submission timing. See our latest analysis for MoonLake Immunotherapeutics. Despite the recent pullback, with a 1-day share price return of 4.57% and a 30-day share price return of 4.31% both declining, MoonLake’s share price is still up 46.86% year to date, while the...
NYSE:NBHC
NYSE:NBHCBanks

A Look At National Bank Holdings (NBHC) Valuation After Recent Share Price Pullback

Setting the stage: what National Bank Holdings stock offers today National Bank Holdings (NBHC) has been drawing attention as investors reassess regional bank stocks, with its US$40.81 share price and recent returns giving a compact snapshot of how the stock has traded recently. See our latest analysis for National Bank Holdings. The recent pullback, with a 7 day share price return of -4.76% and a 30 day share price return of -3.70%, contrasts with a positive year to date share price return...
NYSE:CARR
NYSE:CARRBuilding

How Investors Are Reacting To Carrier Global (CARR) Surging AI‑Driven Data Center HVAC Demand

In the past quarter, Carrier Global reported Q1 2026 sales of US$5.3 billion and a 35% jump in global Commercial HVAC orders, powered by a very large increase in data center demand and new investments in AI-focused cooling technologies. At the same time, Carrier Ventures’ backing of advanced liquid cooling provider ZutaCore underlines how the company is tying its growth in data center orders to next‑generation infrastructure for high‑density AI workloads. Next, we’ll examine how this surge...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

Why TransMedics Group (TMDX) Is Down 6.8% After Mixed Q1 Results And Reaffirmed 2026 Guidance

In early May 2026, TransMedics Group reported first-quarter 2026 results showing revenue of US$173.93 million, up from US$143.54 million a year earlier, but net income fell to US$7.32 million from US$25.68 million and diluted earnings per share from continuing operations declined to US$0.20 from US$0.70. The company also reiterated its full-year 2026 revenue guidance of US$727 million to US$757 million, signaling confidence in continued top-line expansion even as profitability compressed in...
NYSE:HESM
NYSE:HESMOil and Gas

How Reaffirmed 2026 Earnings Guidance and Solid Q1 Results Will Impact Hess Midstream (HESM) Investors

Hess Midstream LP recently reported past first-quarter 2026 results, posting higher year-over-year revenue of US$390.1 million and net income of US$87.6 million, alongside steady operational throughput across most segments. The company also reaffirmed its full-year 2026 net income outlook of US$650 million to US$700 million, signalling confidence in its fee-based midstream model despite mixed volume trends in crude and water gathering. Next, we will examine how reaffirmed 2026 earnings...
NYSE:SF
NYSE:SFCapital Markets

Stifel’s New Energy Infrastructure Project Finance Platform Might Change The Case For Investing In SF

Earlier this month, Stifel Financial Corp. launched a Project Finance platform aimed at funding energy and infrastructure projects using proven commercial technologies, offering development loans, construction-to-term loans, interest rate swaps, depository services, and investment banking advisory support. This expansion builds on Stifel’s newer Energy Tech and Deep Tech teams, signaling a broader push to serve the evolving global energy and infrastructure ecosystem through integrated...
NasdaqGS:MRTN
NasdaqGS:MRTNTransportation

A Look At Marten Transport (MRTN) Valuation After Recent Share Price Momentum And Earnings Weakness

Marten Transport stock moves after recent performance data Marten Transport (MRTN) has drawn fresh attention after recent performance data highlighted both its current valuation and its business mix across truckload, dedicated, and brokerage operations for temperature controlled freight. See our latest analysis for Marten Transport. Recent trading has been a mixed picture, with Marten Transport’s 30 day share price return of 12.87% and year to date share price return of 35.55% contrasting...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

The Bull Case For CorMedix (CRMD) Could Change Following Raised 2026 Guidance And Phase III Results

In May 2026, CorMedix Inc. reported first-quarter 2026 revenue of US$127.43 million and net income of US$38.6 million, and raised its full-year 2026 net revenue guidance to a range of US$325 million to US$345 million. The quarter also featured positive Phase III topline results for REZZAYO in prophylaxis and continued advancement of DefenCath and taurolidine/heparin programs, underscoring how CorMedix is tying commercial growth to late-stage pipeline progress. Next, we’ll explore how...
NasdaqGS:AAON
NasdaqGS:AAONBuilding

AAON (AAON) Valuation Check After Upbeat Q1 Results And Upgraded Full Year Outlook

AAON (AAON) is back in focus after reporting first quarter 2026 results, with sales of US$496.94 million and net income of US$39.82 million, and raising its full year revenue and margin outlook. See our latest analysis for AAON. AAON’s recent earnings upgrade and record backlog have kept the spotlight on the stock. It is now at US$135.49 after a 46.32% 1 month share price return and a 212.35% 5 year total shareholder return, suggesting momentum has been building despite a pullback in the past...
NYSE:PAY
NYSE:PAYDiversified Financial

Paymentus Holdings (PAY) Is Down 8.9% After Raising 2026 Guidance And Launching AI Service Commerce Platform – Has The Bull Case Changed?

Earlier this month, Paymentus Holdings reported first-quarter 2026 results with revenue of US$358.44 million and net income of US$20.88 million, raised its full-year 2026 revenue guidance to US$1.43 billion–US$1.44 billion, and issued second-quarter revenue guidance of US$340 million–US$350 million. The company also introduced its patented Billeo™ and BillWallet® offerings and broader AI-native Service Commerce platform, aiming to turn bills and other transactional documents into...